Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. UPXI
UPXI logo

UPXI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Upexi Inc (UPXI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.940
1 Day change
-2.89%
52 Week Range
22.570
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Upexi Inc (UPXI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth, its financial performance is marred by substantial net losses and negative EPS. The technical indicators are neutral, and there are no strong trading signals or positive catalysts to justify immediate investment. The options data suggests a bullish sentiment, but this alone is insufficient to recommend a buy given the overall context.

Technical Analysis

The MACD is positive but contracting, indicating a lack of strong momentum. RSI is neutral at 51.692, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 0.837, with key resistance at 1.078 and support at 0.597.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • Revenue growth of 101.02% YoY and gross margin improvement to 81.44% indicate operational efficiency improvements.

Neutral/Negative Catalysts

  • Net income remains significantly negative (-178,924,930), and EPS is deeply in the red (-2.94). Analyst price target was lowered from $6 to $2, reflecting diminished confidence. No recent news or significant insider/hedge fund activity.

Financial Performance

In Q2 2026, revenue increased by 101.02% YoY, but net income worsened significantly (-178,924,930, up 13,649.60% YoY). EPS improved slightly but remains negative (-2.94). Gross margin improved to 81.44%, up 19.29% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Cantor Fitzgerald analyst lowered the price target from $6 to $2 while maintaining an Overweight rating, reflecting reduced confidence in the stock's near-term potential.

Wall Street analysts forecast UPXI stock price to rise
1 Analyst Rating
Wall Street analysts forecast UPXI stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.970
sliders
Low
6
Averages
6
High
6
Current: 0.970
sliders
Low
6
Averages
6
High
6
Cantor Fitzgerald
Brett Knoblauch
Overweight
downgrade
$6 -> $2
AI Analysis
2026-02-11
Reason
Cantor Fitzgerald
Brett Knoblauch
Price Target
$6 -> $2
AI Analysis
2026-02-11
downgrade
Overweight
Reason
Cantor Fitzgerald analyst Brett Knoblauch lowered the firm's price target on Upexi to $2 from $6 and keeps an Overweight rating on the shares following the Q2 results. The firm continues to believe the Solana ecosystem is one of the most "vibrant" ecosystems across crypto, and while recent price performance paints a negative light on Solana, the core thesis that Solana can be the internet of capital markets remains true, the analyst tells investors in a research note.
Cantor Fitzgerald
Overweight -> NULL
downgrade
$16 -> $6
2025-11-14
Reason
Cantor Fitzgerald
Price Target
$16 -> $6
2025-11-14
downgrade
Overweight -> NULL
Reason
Cantor Fitzgerald lowered the firm's price target on Upexi to $6 from $16 and keeps an Overweight rating on the shares. With a large SOL treasury, discounted valuation, and new share repurchase authorization, the setup offers an appealing risk/reward profile, the analyst tells investors in a research note. The firm has removed the value applied to its treasury operations from its model.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for UPXI
Unlock Now

People Also Watch